rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
8
|
pubmed:dateCreated |
2005-10-10
|
pubmed:abstractText |
In this report, the authors present the results from a study of patients with unresectable oropharyngeal squamous cell carcinomas who were treated on a protocol of hyperfractionated radiation and high-dose intraarterial cisplatin (HYPERRADPLAT) at the University of Kentucky.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0008-543X
|
pubmed:author |
pubmed-author:ArnoldSusanne MSM,
pubmed-author:GivenCurtisC,
pubmed-author:HaydonRichard CRC3rd,
pubmed-author:KenadyDanielD,
pubmed-author:KudrimotiMaheshM,
pubmed-author:LeeCharlesC,
pubmed-author:MohiuddinMohammedM,
pubmed-author:RegineWilliam FWF,
pubmed-author:SloanDavidD,
pubmed-author:SpringPaul MPM,
pubmed-author:ValentinoJosephJ
|
pubmed:copyrightInfo |
Copyright 2005 American Cancer Society
|
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
104
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1765-71
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16149090-Adult,
pubmed-meshheading:16149090-Aged,
pubmed-meshheading:16149090-Antineoplastic Agents,
pubmed-meshheading:16149090-Carcinoma, Squamous Cell,
pubmed-meshheading:16149090-Cisplatin,
pubmed-meshheading:16149090-Combined Modality Therapy,
pubmed-meshheading:16149090-Dose Fractionation,
pubmed-meshheading:16149090-Female,
pubmed-meshheading:16149090-Head and Neck Neoplasms,
pubmed-meshheading:16149090-Humans,
pubmed-meshheading:16149090-Infusions, Intra-Arterial,
pubmed-meshheading:16149090-Male,
pubmed-meshheading:16149090-Middle Aged,
pubmed-meshheading:16149090-Oropharyngeal Neoplasms,
pubmed-meshheading:16149090-Prospective Studies,
pubmed-meshheading:16149090-Survival Rate,
pubmed-meshheading:16149090-Thiosulfates,
pubmed-meshheading:16149090-Time Factors
|
pubmed:year |
2005
|
pubmed:articleTitle |
Long-term results of hyperfractionated radiation and high-dose intraarterial cisplatin for unresectable oropharyngeal carcinoma.
|
pubmed:affiliation |
Division of Otolaryngology-Head and Neck Surgery, University of Kentucky Chandler Medical Center, Lexington, Kentucky, USA. pspring@uams.edu
|
pubmed:publicationType |
Journal Article,
Comparative Study
|